Surface receptors that regulate the NK cell function: Beyond the NK cell scope

Current Topics in Microbiology and Immunology

Volumn 266, Issue , 2002, Pages 11-22

  Moretta, L ^a   Biassoni, R ^a   Bottino, C ^a   Mingari, M C ^a   Moretta, A ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; HLA ANTIGEN CLASS 1; KILLER INHIBITORY RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; BONE MARROW CELL; CELL ACTIVATION; CELL FUNCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036214359     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-662-04700-2_2     Document Type: Review

References (63)

1. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
2. Transforming growth factor-β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes
3. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity
4. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules
5. The human Leukocyte Antigen (HLA)-C-specific "activatory" or "inhibitory" Natural Killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
6. + cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor
7. Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from Natural Killer cell-mediated lysis
8. The human major histocompatibility complex class Ib molecule HLA-E binds signals-derived peptides with primary anchor residues at position 2 and 9
9. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
10. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
11. p49, a novel putative HLA-class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
12. The activating form of CD94 receptor complex. The CD94-associated Kp39 protein represents the product of the NKG2-C gene
13. The CD94 and NKG2-A C-type lectins covalently assemble to form a NK cell inhibitory receptor for HLA class I molecules
14. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing
15. Self class I molecules protect normal cells from lysis mediated by autologous Natural Killer cells
16. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
17. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions
18. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family which functions as an inhibitory receptor in human natural killer cells
19. + myeloid precursors
20. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells
21. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
22. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses
23. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48
24. NK cell receptors
25. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes
26. The developmental relationship between NK cells and T cells
27. Immunoreceptor DAP12 bearing a tyrosine-based activation motifs is involved in activating NK cells
28. Identification of the 2B4 molecule as a counter-receptor for CD48
29. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
30. In search of the "missing self". MHC molecules and NK cell recognition
31. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells
32. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: Role of different signal peptides
33. Regulation of KIR expression in human T lymphocytes. A safety mechanism which may impair protective T cell responses
34. + T cells
35. + cells from human thymocyte precursors
36. Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production
37. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell population
38. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: Molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells
39. Interleukin-15-induced maturation of human Natural Killer cells from early thymic precursors. Selective expression of CD94/NKG2A as the only HLA-class I specific inhibitory receptor
40. Human NK cells: Origin, clonality, specificity and receptors
41. The natural cytotoxicity receptors that trigger the human NK-mediated cytolysis
42. Allorecognition by NK cells: Nonself or no self?
43. Receptors for HLA-class I-molecules in human Natural Killer cells
44. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human Natural Killer cells
45. Major histocompatibility complex class I-specific receptors on human Natural Killer and T lymphocytes
46. CD69-mediated pathway of lymphocyte activation. Anti-CD69 mAbs trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing TCR α/β
47. Activating interactions in human NK cell recognition: The role of 2B4-CD48
48. Identificaiton and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes
49. Human killer cell activatory are included in a multimeric complex expressed by Natural Killer cells
50. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
51. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of Natural cytotoxicity
52. p40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony stimulating factor
53. A population of early fetal thymocytes expressing FcγRII/III contains precursors of T lymphocytes and natural killer cells
54. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways
55. p46, a novel natural killer cell-specific surface molecule which mediates cell activation
56. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh of cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells
57. 2B4 functions a co-receptor in human Natural Killer cell activation
58. Biology of natural killer cells
59. The sialoadhesin CD33 is myeloid-specific inhibitory receptor
60. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes
61. Engagement of p75/AIRMI or CD33 inhibits the proliferation of normal or leukemic myeloid cells
62. NKp44, a novel triggering surface molecule specifically expressed by activated Natural Killer cells is involved in non-MHC restricted tumor cell lysis
63. Surface expression and function of p75/AIRM1 or CD33 in acute myeloid leukemias. Engagement of CD33 induces apoptosis of leukemic cells